Announcements
- Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
- Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
- Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
- Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
- Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days
- Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024
- Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
More ▼
Key statistics
As of last trade, Xenon Pharmaceuticals Inc (XP0:DUS) traded at 35.40, 38.28% above the 52 week low of 25.60 set on Nov 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.20 |
---|---|
High | 35.40 |
Low | 35.20 |
Bid | 35.40 |
Offer | 35.80 |
Previous close | 34.60 |
Average volume | 16.22 |
---|---|
Shares outstanding | 75.47m |
Free float | 74.29m |
P/E (TTM) | -- |
Market cap | 2.90bn USD |
EPS (TTM) | -2.71 USD |
Data delayed at least 15 minutes, as of May 24 2024 15:30 BST.
More ▼